Comparison of Preemptive Oral Gabapentin versus Pregabalin for Postoperative Pain Management after Lower Limb Surgeries under Spinal Anesthesia: A Prospective Randomized Study.

Authors

P Divya, Shakti Singhal, Gunjan Agarwal, Ghanshyam D Singhal, Preeti Goyal

Published in

Annals of African medicine. Oct 19, 2026. Epub Oct 19, 2026.

Abstract

This study aimed to compare oral Gabapentin and Pregabalin as preemptive analgesics in lower limb surgeries under spinal anesthesia, evaluating their effectiveness in postoperative pain relief and reduction of opioid consumption.
This prospective, randomized, double-blind study included 140 American Society of Anaesthesiologists physical status I-II patients aged 18-60 years scheduled for elective lower limb surgery under spinal anesthesia. Patients received either oral gabapentin 1200 mg or oral pregabalin 300 mg 1 h before surgery. Postoperative pain was assessed using the Visual Analogue Scale (VAS) for 24 h. Time to first rescue analgesia, total tramadol consumption, sedation score, postoperative nausea and vomiting, and adverse effects were recorded. A P < 0.05 was considered statistically significant.
No significant difference in VAS scores was observed between the groups during the first 2 postoperative h. However, from the 3rd postoperative h onward, VAS scores were significantly lower in the pregabalin group (P < 0.001). The mean time to first rescue analgesia was significantly longer in the pregabalin group compared to the gabapentin group (395.57 ± 91.17 min vs. 340.29 ± 57.58 min; P < 0.001). Total tramadol consumption during the first 24 h was significantly lower in the pregabalin group (121.71 ± 17.53 mg vs. 153.57 ± 34.47 mg; P < 0.001). The incidence of adverse effects was comparable between the groups.
In lower limb surgeries under spinal anesthesia, oral Pregabalin provides better postoperative analgesia than oral Gabapentin, with longer pain relief, reduced opioid requirement, and similar side effects.

PMID:
42893841
Bibliographic data and abstract were imported from PubMed on 19 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.